Education
About Us
Working with TipRanks
Follow Us
Immunicum AB (DE:1YG0)
FRANKFURT:1YG0
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 5.05M | kr 28.49M | kr 3.00M | kr 6.00K | kr 0.00 |
| Gross Profit | kr -6.52M | kr 28.49M | kr -1.85M | kr -1.84M | kr -1.77M |
| Operating Income | kr -130.66M | kr -100.65M | kr -133.68M | kr -130.10M | kr -86.03M |
| EBITDA | kr -124.16M | kr -97.85M | kr -128.67M | kr -128.28M | kr -84.25M |
| Net Income | kr -128.40M | kr -101.62M | kr -136.99M | kr -136.69M | kr -92.47M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 101.91M | kr 120.78M | kr 41.85M | kr 155.31M | kr 167.64M |
| Total Assets | kr 696.36M | kr 755.95M | kr 620.39M | kr 720.98M | kr 728.66M |
| Total Debt | kr 22.71M | kr 24.49M | kr 78.16M | kr 36.98M | kr 35.04M |
| Net Debt | kr -79.20M | kr -96.29M | kr 36.31M | kr -118.34M | kr -132.60M |
| Total Liabilities | kr 51.22M | kr 51.23M | kr 105.95M | kr 64.24M | kr 67.57M |
| Stockholders' Equity | kr 645.15M | kr 704.73M | kr 514.44M | kr 656.74M | kr 661.09M |
| Cash Flow | |||||
| Free Cash Flow | kr -81.51M | kr -164.58M | kr -121.43M | kr -139.39M | kr -57.09M |
| Operating Cash Flow | kr -79.67M | kr -162.76M | kr -109.33M | kr -138.03M | kr -56.63M |
| Investing Cash Flow | kr -1.58M | kr -442.00K | kr -12.32M | kr -1.36M | kr 157.30M |
| Financing Cash Flow | kr 61.52M | kr 242.10M | kr 8.19M | kr 127.03M | kr 50.90M |
Immunicum AB Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.